RE:RE:The future That is indeed encouraging. I would guess that's all colon/breast sentry revenues which they finally seem to have found a little traction for with the new contacts they've made through Covid. The one encouraging part of this whole clinic purchase is that SZLS has probably pretty much guaranteed themselves annual revenues of 5-10 million moving forward. This is important as Covid testing peters out at some point, and their pretty abysmal track record for cancer related revenue before this point. Again, not the potential tens of millions some might have hoped for with the launch of Aristotle, but it does provide some security and a solid starting point from which to grow and move forward.
JHendrix wrote: According to Q4 report SZLS did almost $500k in cancer tests. Rest of revenue was COVID tests.